spacer
home > ict > autumn 2020 > direct-to-patient trials – improving patient engagement
PUBLICATIONS
International Clinical Trials

Direct-to-Patient Trials – Improving Patient Engagement

Society is evolving rapidly, especially in response to the COVID-19 pandemic. New technologies are changing the way we communicate, and vast amounts of information are readily available, introducing a new era of personalisation. This has resulted in patient needs becoming the focus of clinical studies. With patients taking more control of their own health and treatment options, the advantages and challenges of different trial methods are magnified.

A Patient-Centric Clinical Trial Model

The traditional method of patients visiting their clinical trial site to pick up medication can disrupt the patient’s day-to-day life. Today, this can be minimised by sponsors implementing a direct-to-patient (DtP) model into their study design.

With clinical supplies prepared, packaged, labelled, and then shipped directly to the home of the patient or caregiver, DtP ensures that trial participants are no longer required to visit the clinical site, which has become even more challenging in light of COVID-19.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sarah Halmrast has 20 years’ experience in project management, primarily in clinical supplies. She initially joined CSM, which later became part of Clinigen Group, as a pharmacy technician and held various roles within the company before becoming the Vice President, Global Project Management, in 2018. Leading the Project Management departments in the US and the EU, her role is critical to ensure harmonisation of practices for clients to experience the same service levels, regardless of their geographical location. Sarah has a Pharmacy Technician degree from North Dakota State College of Science, US, and a Bachelor’s degree in Business Management from the University of Mary, US.

shalmrast@csmondemand.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

Thermo Fisher Scientific Adds Patterned Microchip-based Technology to Liquid Chromatography Portfolio

PHILADELPHIA – ASMS 2021 – (November 1, 2021) – Thermo Fisher Scientific, the world leader in serving science, today announced its acquisition of Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography column.
More info >>

White Papers

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

PCI Pharma Services

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets (1). It discovered the product was shipped by sea from India to multiple companies in the UK at temperatures reaching up to 60 degrees Celsius. Labeling for paracetamol tablets typically states they should be kept below 30 degrees Celsius. In addition, MHRA discovered the humidity levels exceeded 80 percent during shipping, which is too high for the packaging that was used.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement